Pennant Investors’s Nurix Therapeutics NRIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-56,800
Closed -$1.19M 34
2024
Q2
$1.19M Hold
56,800
0.31% 16
2024
Q1
$835K Hold
56,800
0.21% 15
2023
Q4
$586K Buy
+56,800
New +$586K 0.13% 12